You just read:

Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris' ADAPT Biotargeting System in the Development Program for Evofosfamide

News provided by

Caris Life Sciences

Oct 25, 2016, 08:00 ET